BARK INC (BARK) Fundamental Analysis & Valuation

NYSE:BARK • US68622E1047

Current stock price

9.01 USD
+0.16 (+1.81%)
Last:

This BARK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. BARK Profitability Analysis

1.1 Basic Checks

  • In the past year BARK has reported negative net income.
  • BARK had a negative operating cash flow in the past year.
  • In the past 5 years BARK always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: BARK reported negative operating cash flow in multiple years.
BARK Yearly Net Income VS EBIT VS OCF VS FCFBARK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

  • The Return On Assets of BARK (-17.18%) is worse than 78.69% of its industry peers.
  • With a Return On Equity value of -39.90%, BARK is not doing good in the industry: 68.85% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.18%
ROE -39.9%
ROIC N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BARK Yearly ROA, ROE, ROICBARK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

  • With an excellent Gross Margin value of 61.59%, BARK belongs to the best of the industry, outperforming 91.80% of the companies in the same industry.
  • BARK's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for BARK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.59%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
BARK Yearly Profit, Operating, Gross MarginsBARK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. BARK Health Analysis

2.1 Basic Checks

  • BARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, BARK has less shares outstanding
  • BARK has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, BARK has a worse debt to assets ratio.
BARK Yearly Shares OutstandingBARK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
BARK Yearly Total Debt VS Total AssetsBARK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

  • BARK has an Altman-Z score of -0.54. This is a bad value and indicates that BARK is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -0.54, BARK is not doing good in the industry: 79.51% of the companies in the same industry are doing better.
  • BARK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.54
ROIC/WACCN/A
WACC5.88%
BARK Yearly LT Debt VS Equity VS FCFBARK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

  • BARK has a Current Ratio of 1.85. This is a normal value and indicates that BARK is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.85, BARK is in the better half of the industry, outperforming 73.77% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that BARK may have some problems paying its short term obligations.
  • BARK's Quick ratio of 0.63 is in line compared to the rest of the industry. BARK outperforms 54.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.85
Quick Ratio 0.63
BARK Yearly Current Assets VS Current LiabilitesBARK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. BARK Growth Analysis

3.1 Past

  • BARK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -133.33%.
  • Looking at the last year, BARK shows a very negative growth in Revenue. The Revenue has decreased by -13.58% in the last year.
  • BARK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.64% yearly.
EPS 1Y (TTM)-133.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-22.14%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.93% on average over the next years. This is quite good.
  • Based on estimates for the next years, BARK will show a small growth in Revenue. The Revenue will grow by 0.59% on average per year.
EPS Next Y-333.5%
EPS Next 2Y-33.6%
EPS Next 3Y59.27%
EPS Next 5Y17.93%
Revenue Next Year-18.39%
Revenue Next 2Y-8.57%
Revenue Next 3Y-3.57%
Revenue Next 5Y0.59%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BARK Yearly Revenue VS EstimatesBARK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
BARK Yearly EPS VS EstimatesBARK Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

1

4. BARK Valuation Analysis

4.1 Price/Earnings Ratio

  • BARK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year BARK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BARK Price Earnings VS Forward Price EarningsBARK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BARK Per share dataBARK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

  • BARK's earnings are expected to grow with 59.27% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-33.6%
EPS Next 3Y59.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BARK Dividend Analysis

5.1 Amount

  • No dividends for BARK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BARK Fundamentals: All Metrics, Ratios and Statistics

BARK INC

NYSE:BARK (4/14/2026, 10:17:30 AM)

9.01

+0.16 (+1.81%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)02-05
Earnings (Next)06-02
Inst Owners42.09%
Inst Owner Change-100%
Ins Owners14.41%
Ins Owner Change-0.66%
Market Cap77.85M
Revenue(TTM)423.69M
Net Income(TTM)-32.41M
Analysts82.22
Price Target40.8 (352.83%)
Short Float %N/A
Short Ratio15.97
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-34.8%
Min EPS beat(2)-96.08%
Max EPS beat(2)26.47%
EPS beat(4)2
Avg EPS beat(4)2.4%
Min EPS beat(4)-96.08%
Max EPS beat(4)109.93%
EPS beat(8)6
Avg EPS beat(8)382.41%
EPS beat(12)9
Avg EPS beat(12)257.86%
EPS beat(16)11
Avg EPS beat(16)185.16%
Revenue beat(2)1
Avg Revenue beat(2)-3.01%
Min Revenue beat(2)-7.32%
Max Revenue beat(2)1.31%
Revenue beat(4)2
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-10.76%
Max Revenue beat(4)1.31%
Revenue beat(8)3
Avg Revenue beat(8)-2.47%
Revenue beat(12)4
Avg Revenue beat(12)-1.93%
Revenue beat(16)5
Avg Revenue beat(16)-1.39%
PT rev (1m)1900%
PT rev (3m)1614.31%
EPS NQ rev (1m)-3100%
EPS NQ rev (3m)-3900%
EPS NY rev (1m)-1316.67%
EPS NY rev (3m)-1260%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF N/A
P/B 0.96
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-1.4
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-4.22
FCFYN/A
OCF(TTM)-3.71
OCFYN/A
SpS49.04
BVpS9.4
TBVpS9.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.18%
ROE -39.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.59%
FCFM N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
F-Score5
Asset Turnover2.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.16%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.85
Quick Ratio 0.63
Altman-Z -0.54
F-Score5
WACC5.88%
ROIC/WACCN/A
Cap/Depr(3y)117.01%
Cap/Depr(5y)206.52%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-50%
EPS Next Y-333.5%
EPS Next 2Y-33.6%
EPS Next 3Y59.27%
EPS Next 5Y17.93%
Revenue 1Y (TTM)-13.58%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-22.14%
Revenue Next Year-18.39%
Revenue Next 2Y-8.57%
Revenue Next 3Y-3.57%
Revenue Next 5Y0.59%
EBIT growth 1Y1.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year91.34%
EBIT Next 3Y32.47%
EBIT Next 5Y23.31%
FCF growth 1Y-313.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-221.98%
OCF growth 3YN/A
OCF growth 5YN/A

BARK INC / BARK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BARK INC (BARK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BARK.


Can you provide the valuation status for BARK INC?

ChartMill assigns a valuation rating of 1 / 10 to BARK INC (BARK). This can be considered as Overvalued.


How profitable is BARK INC (BARK) stock?

BARK INC (BARK) has a profitability rating of 1 / 10.


What is the financial health of BARK INC (BARK) stock?

The financial health rating of BARK INC (BARK) is 5 / 10.